These results suggested that tumor-infiltrating Th17 cells stimulated tumor tissues to express CCL2/20 for recruiting various inflammatory leukocytes, such as DCs, CD4+, and CD8+ T cells to induce antitumorimmunity (34, 38). The gene discussed is CCL2; the disease is neoplasm.